To assess the impact of the COVID-19 pandemic on health and HIV expenditure, UNAIDS carried out a modelling study on fiscal space for health and HIV. From a sample of 28 countries, three countries—the Democratic Republic of the Congo, Jamaica, and Lesotho—were selected to capture health and HIV ...expenditure impacts across countries with especially marked differences in burdens of disease (including HIV prevalence), HIV donor dependency, level of economic development, and geographic location. While the three-country sample is too small to permit findings to be generalized to other countries, these analyses are useful for informing UNAIDS’ work to identify some policy positions to minimize the COVID-19 pandemic’s impact on the HIV response.
more
HIV & AIDS Treatment in Practice No.202
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release...d the report – drug-resistant diseases could cause 10 million deaths each year by 2050 and damage to the economy as catastrophic as the 2008-2009 global financial crisis. By 2030, antimicrobial resistance could force up to 24 million people into extreme poverty.
more
12-13 December 2016
Global Action Plan on HIV Drug Resistance - Webinars 12-13 December 2016
AIDSTAR-One | CASE STUDY SERIES November 2012
Regional action plan 2019-2023
These updates include shorter novel 6-month all-oral regimens for the treatment of multidrug- and rifampicin-resistant TB (MDR/RR-TB), with or without additional resistance to fluoroquinolones (pre-XDR-TB) as well as an alternative 9-month all-oral regimen for the treatment of MDR/RR-TB.
This Ra...pid Communication is released in advance of updated WHO consolidated guidelines expected later in 2022, to inform national TB programmes and other stakeholders of key changes in the treatment of DR-TB and to allow for rapid transition and planning at the country level.
more
Die neuen Podcast-Folgen werden dienstags gegen 17 Uhr veröffentlicht. Neben Christian Drosten, dem Leiter der Virologie an der Berliner Charité, ist Sandra Ciesek, Direktorin des Instituts für Medizinische Virologie am Universitätsklinikum Frankfurt am Main, ein regelmäßiger Gesprächsgast.
...Seit Ende Februar 2020 beantwortet Prof. Dr. Christian Drosten (Leiter der Virologie an der Berliner Charité) Fragen zur aktuellen Situation, erklärt Zusammenhänge und schildert, wie er diese Monate persönlich erlebt. Anfang September kam Prof. Dr. Sandra Ciesek (Leiterin der Virologie des Universitätsklinikums Frankfurt) als Gesprächsgast dazu.
more